Cited by 431Treatment of Major DepressionMental Health Treatment and AccessAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 148 of the 150 references it cites were found in a registry or an index.

Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.

Lam, Raymond W., Kennedy, Sidney H., Grigoriadis, Sophie, McIntyre, Roger S., Milev, Roumen, Ramasubbu, Rajamannar, Parikh, Sagar V., Patten, Scott B., Ravindran, Arun V.·2009·Journal of Affective Disorders

DOI 10.1016/j.jad.2009.06.041

Open this paper in CoChat — free account

Abstract

Background In 2001, the Canadian Psychiatric Association and the Canadian Network for Mood and Anxiety Treatments (CANMAT) partnered to produce evidence-based clinical guidelines for the treatment of depressive disorders. A revision of these guidelines was undertaken by CANMAT in 2008-2009 to reflect advances in the field. Methods The CANMAT guidelines are based on a question-answer format to enhance accessibility to clinicians. An evidence-based format was used with updated systematic reviews of the literature and recommendations were graded according to Level of Evidence using pre-defined criteria. Lines of Treatment were identified based on criteria that included Levels of Evidence and expert clinical support. This section on "Pharmacotherapy" is one of 5 guideline articles. Results Despite emerging data on efficacy and tolerability differences amongst newer antidepressants, variability in patient response precludes identification of specific first choice medications for all patients. All second-generation antidepressants have Level 1 evidence to support efficacy and tolerability and most are considered first-line treatments for MDD. First-generation tricyclic and monoamine oxidase inhibitor antidepressants are not the focus of these guidelines but generally are considered second- or third-line treatments. For inadequate or incomplete response, there is Level 1 evidence for switching strategies and for add-on strategies including lithium and atypical antipsychotics. Limita…

Integrity signals

Registry

Crossref · 10.1016/j.jad.2009.06.041

Cites

148 of 148 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
The Serotonin Syndrome
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQUEEN, G. M., McIntyre, R. S., Sharma, V., et al. (2012) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,230
Self-citation
Clinical Response and Risk for Reported Suicidal Ideation and Suicide Attempts in Pediatric Antidepressant Treatment: A Meta-analysis of Randomized Controlled Trials
Bridge, J. A., Iyengar, S., Salary, C. B., Barbe, R. P., Birmaher, B., Pincus, H. A., Ren, L., & Brent, D. A. (2007) · JAMA · doi:10.1001/jama.297.15.1683 · Cited by 1,086
Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076
Suicidality in Pediatric Patients Treated With Antidepressant Drugs
Hammad, T. A., Laughren, T., & Racoosin, J. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.332 · Cited by 1,054
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, A. A., Thase, M. E., Ritz, L., Biggs, M. M., Warden, D., Luther, J. F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052963 · Cited by 1,033
Medication Augmentation after the Failure of SSRIs for Depression
Trivedi, M. H., Fava, M., Wisniewski, S. R., Thase, M. E., Quitkin, F., Warden, D., Ritz, L., Nierenberg, A. A., Lebowitz, B. D., Biggs, M. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052964 · Cited by 1,002

Flagged first, then by citations

Show all 150 references

2 of the 150 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Lam, 2004, Prescribing antidepressants for depression in 2005: recent concerns and recommendations, Can. J. Psychiatry, 49, 1

Sorted by citations

Items 101–200 of 431

Evaluation of an electronic consultation service in psychiatry for primary care providers
Archibald, D., Stratton, J., Liddy, C., Grant, R. E., Green, D., & Keely, E. J. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1701-3 · Cited by 46
The Efficacy and Tolerability of Bupropion in the Treatment of Major Depressive Disorder
Moreira, R. (2011) · Clinical Drug Investigation · doi:10.2165/1159616-s0-000000000-00000 · Cited by 50
Neural response to emotional stimuli associated with successful antidepressant treatment and behavioral activation
Rizvi, S. J., Salomons, T. V., Konarski, J. Z., Downar, J., Giacobbe, P., McIntyre, R. S., & Kennedy, S. H. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.050 · Cited by 45
Self-citation
RECURRENCE OF MAJOR DEPRESSIVE EPISODES IS STRONGLY DEPENDENT ON THE NUMBER OF PREVIOUS EPISODES: Recurrence of Major Depressive Episodes and Previous Episodes
Bulloch, A., Williams, J., Lavorato, D., & Patten, S. (2014) · Depression and Anxiety · doi:10.1002/da.22173 · Cited by 45
Self-citation
Optimizing the management of depression: primary care experience
Cameron, C., Habert, J., Anand, L., & Furtado, M. (2014) · Psychiatry Research · doi:10.1016/s0165-1781(14)70005-8 · Cited by 46
Korean Medication Algorithm for Depressive Disorders 2017: Third Revision
Seo, J. S., Bahk, W., Wang, H. R., Woo, Y. S., Park, Y. M., Jeong, J., Kim, W. K., Shim, S.-H., Lee, J. G., Jon, D., et al. (2018) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2018.16.1.67 · Cited by 44
Development and validation of a prediction algorithm for use by health professionals in prediction of recurrence of major depression
Wang, J. L., Patten, S., Sareen, J., Bolton, J., Schmitz, N., & MacQueen, G. (2014) · Depression and Anxiety · doi:10.1002/da.22215 · Cited by 43
Self-citation
Treatment Options for the Cardinal Symptoms of Disruptive Mood Dysregulation Disorder.
Tourian, L., LeBoeuf, A., Breton, J., Cohen, D., Gignac, M., Labelle, R. J., Guilé, J.-M., & Renaud, J. (2015) · Europe PMC (PubMed Central) · Cited by 43
An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth
BENNETT, K. J., Courtney, D., Duda, S. J., Henderson, J. L., & Szatmári, P. (2018) · Depression and Anxiety · doi:10.1002/da.22752 · Cited by 44
The effectiveness of prefrontal theta cordance and early reduction of depressive symptoms in the prediction of antidepressant treatment outcome in patients with resistant depression: analysis of naturalistic data
Bareš, M., Novák, T., Kopeček, M., Brunovský, M., Stopková, P., & Höschl, C. (2014) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0506-8 · Cited by 42
Sex Differences in Responses to Antidepressant Augmentations in Treatment-Resistant Depression
Moderie, C., Núñez, N. A., Fielding, A., Comai, S., & Gobbi, G. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac017 · Cited by 44
A Review of Antidepressant Therapy in Primary Care
Kennedy, S. H. (2013) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.12r01420 · Cited by 41
Self-citation
Pharmacological and combined interventions for the acute depressive episode: focus on efficacy and tolerability
Fregni, F., Brunoni, & Fráguas, R. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s5751 · Cited by 40
Psychotropic Prescription Patterns Among Patients Diagnosed With Depressive Disorder Based on Claims Database in Japan
Onishi, Y., Hinotsu, S., Furukawa, T. A., & Kawakami, K. (2013) · Clinical Drug Investigation · doi:10.1007/s40261-013-0104-y · Cited by 39
Sleep disturbances and suicidal ideation in a sample of treatment-seeking Canadian Forces members and veterans
Richardson, J. A., Cyr, K. S., Nelson, C. G., Elhai, J. D., & Sareen, J. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.04.008 · Cited by 41
Are antidepressants effective? A debate on their efficacy for the treatment of major depression in adults
Bschor, T., & Kilarski, L. L. (2016) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2016.1155985 · Cited by 43
Evidence-Based Medicine: Opportunities and Challenges in a Diverse Society
Whitley, R., Rousseau, C., Carpenter-Song, E., & Kirmayer, L. J. (2011) · Canadian journal of psychiatry. Revue canadienne de psychiatrie · doi:10.1177/070674371105600902 · Cited by 40
Psychotherapy for Major Depressive Disorder and Generalized Anxiety Disorder: A Health Technology Assessment.
(2017) · Europe PMC (PubMed Central) · Cited by 37
Impact of non-remission of depression on costs and resource utilization: from the COmorbidities and symptoms of DEpression (CODE) study
Dennehy, E. B., Robinson, R. L., Stephenson, J. J., Faries, D. E., Grabner, M., Palli, S. R., Stauffer, V. L., & Marangell, L. B. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1029893 · Cited by 40
Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
Chiuccariello, L., Cooke, R. G., Miler, L., Levitan, R. D., Baker, G. B., Kish, S. J., Kolla, N. J., Rusjan, P., Houle, S., Wilson, A. A., et al. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv078 · Cited by 36
California State Hospital Violence Assessment and Treatment (Cal-VAT) guidelines
Stahl, S. M., Morrissette, D. A., Cummings, M. A., Azizian, A., Bader, S. M., Broderick, C., Dardashti, L. J., Delgado, D., Meyer, J. M., O’Day, J., et al. (2014) · CNS Spectrums · doi:10.1017/s1092852914000376 · Cited by 37
Suizidprophylaktische Wirkung von Lithium
Lewitzka, U., Bauer, M., Felber, W., & Müller-Oerlinghausen, B. (2012) · Der Nervenarzt · doi:10.1007/s00115-012-3542-5 · Cited by 36
Collaborating in the context of co-location: a grounded theory study
Wener, P. F., & Woodgate, R. L. (2016) · BMC Family Practice · doi:10.1186/s12875-016-0427-x · Cited by 38
Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study
Valachis, A., Garmo, H., Weinman, J. A., Fredriksson, I., Ahlgren, J., Sund, M., & Holmberg, L. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3928-3 · Cited by 37
The role of outcome expectancy in therapeutic change across psychotherapy versus pharmacotherapy for depression
Thiruchselvam, T., Dozois, D. J. A., Bagby, R. M., Lobo, D. S. S., Ravindran, L. N., & Quilty, L. C. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.01.046 · Cited by 35
Efficacy and cost-effectiveness of intensive short-term dynamic psychotherapy for treatment resistant depression: 18-Month follow-up of the Halifax depression trial
Town, J. M., Abbass, A. A., Stride, C., Nunes, A., Bernier, D. C., & Berrigan, P. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.04.035 · Cited by 39
Comparative efficacy of escitalopram in the treatment of major depressive disorder
Lam, R., & Ali (2011) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s12531 · Cited by 33
Self-citation
Update on antidepressant use during breastfeeding.
Chad, L., Pupco, A., Bozzo, P., & Koren, G. (2013) · Europe PMC (PubMed Central) · Cited by 33
Cognitive change in cognitive-behavioural therapy v. pharmacotherapy for adult depression: a longitudinal mediation analysis
Quigley, L., Dozois, D. J. A., Bagby, R. M., Lobo, D. S. S., Ravindran, L. N., & Quilty, L. C. (2018) · Psychological Medicine · doi:10.1017/s0033291718003653 · Cited by 33
Connectivity between the anterior insula and dorsolateral prefrontal cortex links early symptom improvement to treatment response
Yuan, H., Zhu, X. L., Tang, W., Cai, Y., Shi, S., & Luo, Q. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.09.041 · Cited by 31
Evidence review and clinical guidance for the use of ziprasidone in Canada
Gardner, D. M., Murphy, A. L., Kutcher, S., Beaulieu, S., Carandang, C. G., Labelle, A., Lalonde, P., MALLA, A. K., Milliken, H., O’Donovan, C., et al. (2013) · Annals of General Psychiatry · doi:10.1186/1744-859x-12-1 · Cited by 32
Depression in the Primary Care Setting
Ellis, P., Kitay, B. M., & Schmidt, C. J. (2019) · New England Journal of Medicine · doi:10.1056/nejmc1903259 · Cited by 35
Treatment patterns in major depressive disorder after an inadequate response to first-line antidepressant treatment
Garcia-Toro, M., Medina, E., Galan, J. L., Gonzalez, M. A., & Maurino, J. (2012) · BMC Psychiatry · doi:10.1186/1471-244x-12-143 · Cited by 32
Valproate augmentation in a subgroup of patients with treatment-resistant unipolar depression
Ghabrash, M. F., Comai, S., Tabaka, J. M., Saint-Laurent, M., Booij, L., & Gobbi, G. (2015) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2015.1073856 · Cited by 32
Interpersonal psychotherapy as add-on for treatment-resistant depression: A pragmatic randomized controlled trial
de Souza, L. H., Salum, G. A., Mosqueiro, B. P., Caldieraro, M. A., Guerra, T. A., & Fleck, M. P. D. A. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.01.004 · Cited by 32
Antidepressant-dependent mRNA changes in mouse associated with hippocampal neurogenesis in a mouse model of depression
Malki, K., Lourdusamy, A., Binder, E., Paya-Cano, J. L., Sluyter, F., Craig, I., Keers, R., McGuffin, P., Uher, R., & Schalkwyk, L. C. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328356fa90 · Cited by 34
Non-pharmacological Interventions for Caregivers with Depression and Caregivers of Care Recipients with Co-morbid Depression: Systematic Review and Meta-analysis
Lambert, S., Brahim, L. O., McCusker, J., Coumoundouros, C., Audet, L.-A., Yaffe, M., Kayser, J., Magalhaes, M., Belzile, E., & Turner, N. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-021-06891-6 · Cited by 28
Abrupt discontinuation compared with a 1-week taper regimen in depressed outpatients treated for 24 weeks with desvenlafaxine 50 mg/d
Khan, A., Musgnung, J., Ramey, T., Messig, M., Buckley, G., & Ninan, P. T. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000100 · Cited by 30
Effects of Neurofeedback on Adult Patients with Psychiatric Disorders in a Naturalistic Setting
Cheon, E., Koo, B., Seo, W. S., Lee, J.-Y., Choi, J.-H., & Song, S.-H. (2015) · Applied Psychophysiology and Biofeedback · doi:10.1007/s10484-015-9269-x · Cited by 31
Is it worth assessing progress as early as week 2 to adapt antidepressive treatment strategy? Results from a study on agomelatine and a global meta-analysis
Gorwood, P. A. P. M., Bayle, F., Vaïva, G., Courtet, P., Corruble, E., & Llorca, P. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2012.11.004 · Cited by 31
Fluoxetine-induced pancreatic beta cell dysfunction: New insight into the benefits of folic acid in the treatment of depression
Long, N. E. D., Hyslop, J. R., Raha, S., Hardy, D. B., & Holloway, A. C. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.063 · Cited by 34
The clinical effectiveness of evidence-based interventions for depression: A pragmatic trial in routine practice
Peeters, F. P. M. L., Huibers, M. J. H., Roelofs, J., van Breukelen, G., Hollon, S. D., Markowitz, J. C., van Os, J., & Arntz, A. R. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.08.022 · Cited by 31
Antidepressant switching patterns in the treatment of major depressive disorder: a General Practice Research Database (GPRD) Study
Saragoussi, D., Chollet, J., Bineau, S., Chalem, Y., & Milea, D. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.03015.x · Cited by 30
Efficacy of aripiprazole augmentation in J apanese patients with major depressive disorder: A subgroup analysis and Montgomery–Åsberg Depression Rating Scale and Hamilton Rating Scale for Depression item analyses of the Aripiprazole Depression Multicenter Efficacy study
Ozaki, N., Otsubo, T., Kato, M., Higuchi, T., Ono, H., Kamijima, K., & ADMIRE Study Group (2014) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12214 · Cited by 30
Efficacy and tolerability of switching therapy to vortioxetine versus other antidepressants in patients with major depressive disorder
Brignone, M., Diamand, F., Painchault, C., & Takyar, S. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1128404 · Cited by 30
Rational site-directed pharmacotherapy for major depressive disorder
Blier, P. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000400 · Cited by 29
Antidepressant combination versus antidepressants plus second-generation antipsychotic augmentation in treatment-resistant unipolar depression
Gobbi, G., Ghabrash, M. F., Núñez, N. A., Tabaka, J. M., Sante, J. D., Saint-Laurent, M., Vida, S., Kolivakis, T., Low, N. C. P., Cervantes, P., et al. (2017) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000196 · Cited by 29
Examining the Association between Psychiatric Illness and Suicidal Ideation in a Sample of Treatment-Seeking Canadian Peacekeeping and Combat Veterans with Posttraumatic Stress Disorder
Richardson, J. D., Cyr, K. S., McIntyre‐Smith, A., Haslam, D. B., Elhai, J. D., & Sareen, J. (2012) · The Canadian Journal of Psychiatry · doi:10.1177/070674371205700808 · Cited by 28
Depressive episode characteristics and subsequent recurrence risk
Patten, S. B., Williams, J. V. A., Lavorato, D. H., Bulloch, A. G. M., & MacQUEEN, G. M. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.02.006 · Cited by 28
Self-citation
Adequacy of Mental Health Services for HIV-Positive Patients with Depression: Ontario HIV Treatment Network Cohort Study
Choi, S. K. Y., Boyle, E., Cairney, J., Gardner, S. L., Collins, E. J., Bacon, J., Rourke, S. B., & OHTN Cohort Study Group (2016) · PLoS ONE · doi:10.1371/journal.pone.0156652 · Cited by 27
Prevalence, Recurrence, and Incidence of Current Depressive Symptoms among People Living with HIV in Ontario, Canada: Results from the Ontario HIV Treatment Network Cohort Study
Choi, S. K. Y., Boyle, E., Cairney, J., Collins, E., Gardner, S., Bacon, J., & Rourke, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165816 · Cited by 28
Quetiapine: novel uses in the treatment of depressive and anxiety disorders
Ravindran, A. V., Al‐Subaie, A., & Abraham, G. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.515586 · Cited by 26
Self-citation
Comorbid Chronic General Health Conditions and Depression Care: A Population-Based Analysis
Puyat, J. H., Kazanjian, A., Wong, H., & Goldner, E. M. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201600309 · Cited by 29
The Korean medication algorithm for depressive disorder: Second revision
Seo, J. S., Song, H. R., Lee, H. B., Park, Y., Hong, J., Kim, W. K., Wang, H.-R., Lim, E.-S., Jeong, J., Jon, D., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.031 · Cited by 26
High-Dose Citalopram and Escitalopram and the Risk of Out-of-Hospital Death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10324 · Cited by 25
Antipsychotic Medications and Mortality in Children and Young Adults
Ray, W. A., Fuchs, D. C., Olfson, M., Patrick, S. W., Stein, C. M., Murray, K. T., Daugherty, J. R., & Cooper, W. O. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.4573 · Cited by 27
Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders
Slomp, C., Morris, E. M., Edwards, L., Hoens, A. M., Landry, G., Riches, L., Ridgway, L., Bryan, S., & Austin, J. (2022) · The Canadian Journal of Psychiatry · doi:10.1177/07067437221140383 · Cited by 28
Evidence for the Benefits of Nonantipsychotic Pharmacological Augmentation in the Treatment of Depression
Chang, C., Sato, S., & Han, C. (2013) · CNS Drugs · doi:10.1007/s40263-012-0030-1 · Cited by 24
Does lithium reduce acute suicidal ideation and behavior? A protocol for a randomized, placebo-controlled multicenter trial of lithium plus Treatment As Usual (TAU) in patients with suicidal major depressive episode
Lewitzka, U., Jabs, B. E., Fulle, M., Holthoff‐Detto, V., Juckel, G., Uhl, I., Kittel‐Schneider, S., Reif, A., Reif-Leonhard, C., Gruber, O., et al. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0499-5 · Cited by 24
Antenatal exposure to the selective serotonin reuptake inhibitor fluoxetine leads to postnatal metabolic and endocrine changes associated with type 2 diabetes in Wistar rats
Long, N. E. D., Barry, E. J., Pinelli, C. J., Wood, G. A., Hardy, D. B., Morrison, K. M., Taylor, V. H., Gerstein, H. C., & Holloway, A. C. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.03.006 · Cited by 24
Canadian Headache Society Guideline for Migraine Prophylaxis: Supplement 2
Pringsheim, T., Davenport, W. J., Mackie, G. F., Worthington, I., Michel, Aubé, Christie, S., Gladstone, J., & Becker, W. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100015109 · Cited by 17
Efficacy of off-label augmentation in unipolar depression: A systematic review of the evidence
Kleeblatt, J., Betzler, F., Kilarski, L. L., Bschor, T., & Köhler, S. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.03.003 · Cited by 25
Use of Mental Health Telemetry to Enhance Identification and Predictive Value of Early Changes During Augmentation Treatment of Major Depression
Schaffer, A., Kreindler, D., Reis, C., & Levitt, A. J. (2013) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31829e8359 · Cited by 22
Dysfunction in endocannabinoids, palmitoylethanolamide, and degradation of tryptophan into kynurenine in individuals with depressive symptoms
Comai, S., Núñez, N. A., Atkin, T., Ghabrash, M. F., Zakarian, R., Fielding, A., Saint-Laurent, M., Low, N. C. P., Sauber, G., Ragazzi, E., et al. (2024) · BMC Medicine · doi:10.1186/s12916-024-03248-8 · Cited by 22
Predictors of functional response and remission with desvenlafaxine 50 mg/d in patients with major depressive disorder
Soares, C. N., Endicott, J., Boucher, M., Fayyad, R. S., & Guico‐Pabia, C. J. (2014) · CNS Spectrums · doi:10.1017/s1092852914000066 · Cited by 22
Analysis of depressive episodes, their recurrence and pharmacologic treatment in primary care patients: A retrospective descriptive study
Nuggerud-Galeas, S., Suescun, L. S.-B., Torrijo, N. B., Suescun, A. S.-B., Aguilar‐Latorre, A., Botaya, R. M., & Oliván‐Blázquez, B. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233454 · Cited by 23
Pharmacoproteomic investigation into antidepressant response in two mouse inbred strains
Malki, K., Campbell, J., Davies, M., Keers, R., Uher, R., Ward, M. A., Paya-Cano, J. L., Aitchinson, K. J., Binder, E., Sluyter, F., et al. (2012) · PROTEOMICS · doi:10.1002/pmic.201100306 · Cited by 22
EMSAM (deprenyl patch): how a promising antidepressant was underutilized
Asnis, G. M., & Henderson, M. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s59107 · Cited by 22
Escitalopram versus serotonin noradrenaline reuptake inhibitors as second step treatment for patients with major depressive disorder: a pooled analysis
Lam, R. W. M., Lönn, S. L., & Despiégel, N. (2010) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32833948d8 · Cited by 22
Self-citation
Management of Chronic Noncancer Pain in Depressed Patients
Barkin, R. L., Barkin, S. J., Irving, G. A., & GORDON, A. S. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.09.2470 · Cited by 22
Treatment recommendations for DSM-5–defined mixed features
Rosenblat, J. D., & McIntyre, R. S. (2016) · CNS Spectrums · doi:10.1017/s1092852916000432 · Cited by 24
Self-citation
Pharmacogenomic Testing for Psychotropic Medication Selection: A Systematic Review of the Assurex GeneSight Psychotropic Test.
(2017) · Europe PMC (PubMed Central) · Cited by 22
Predictors of Response to Adjunctive Osmotic-Release Methylphenidate or Placebo in Patients With Major Depressive Disorder
Rizvi, S. J., Geraci, J., Ravindran, A. V., & Kennedy, S. H. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000211 · Cited by 24
Self-citation
Prescription patterns following first-line new generation antidepressants for depression in Japan: a naturalistic cohort study based on a large claims database
Furukawa, T. A., Onishi, Y., Hinotsu, S., Tajika, A., Takeshima, N., Shinohara, K., Ogawa, Y., Hayasaka, Y., & Kawakami, K. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.05.015 · Cited by 21
Times to Discontinue Antidepressants Over 6 Months in Patients with Major Depressive Disorder
Jung, W.-Y., Jang, S., Kim, S.-G., Jae, Y. M., Kong, B.-G., Kim, H.-C., Choe, B.-M., Kim, J.-G., & Kim, C.-R. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.4.440 · Cited by 21
Potential of St John's Wort for the Treatment of Depression: The Economic Perspective
Solomon, D., Ford, E., Adams, J., & Graves, N. (2010) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2010.526094 · Cited by 21
The Impact of Antipsychotic Polytherapy Costs in the Public Health Care in Sao Paulo, Brazil
Razzouk, D., Kayo, M., Sousa, A., Gregório, G., Cogo‐Moreira, H., Cardoso, A. A., & Mari, J. D. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124791 · Cited by 21
Conflicts of Interest and the Presence of Methodologists on Guideline Development Panels: A Cross-Sectional Study of Clinical Practice Guidelines for Major Depressive Disorder
Cosgrove, L., Shaughnessy, A. F., Peters, S. M., Lexchin, J., Bursztajn, H. J., & Bero, L. A. (2017) · Psychotherapy and Psychosomatics · doi:10.1159/000458727 · Cited by 20
Management of first depression or generalized anxiety disorder episode in adults in primary care: A systematic metareview
Driot, D., Bismuth, M., Maurel, A., Soulié-Albouy, J., Birebent, J., Oustric, S., & Dupouy, J. (2017) · La Presse Médicale · doi:10.1016/j.lpm.2017.10.010 · Cited by 24
Conflict of Interest Policies and Industry Relationships of Guideline Development Group Members: A Cross-Sectional Study of Clinical Practice Guidelines for Depression
Cosgrove, L., Krimsky, S., Wheeler, E. E., Peters, S. M., Brodt, M., & Shaughnessy, A. (2017) · Accountability in Research · doi:10.1080/08989621.2016.1251319 · Cited by 20
Strategies to achieve clinical effectiveness: Refining existing therapies and pursuing emerging targets
Kennedy, S. H., Young, A. H., & Blier, P. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.048 · Cited by 20
Self-citation
Desvenlafaxine for the treatment of major depressive disorder
Kornstein, S. G., McIntyre, R. S., Thase, M. E., & Boucher, M. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.923403 · Cited by 21
Self-citation
Adjunctive Brexpiprazole as a Novel Effective Strategy for Treating Major Depressive Disorder
Yoon, S., Jeon, S. W., Ko, Y., Patkar, A. A., Masand, P. S., Pae, C., & Han, C. (2016) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000622 · Cited by 20
Efficacy, acceptability, and safety of adjunctive aripiprazole in treatment-resistant depression: a meta-analysis of randomized controlled trials
Luan, S., Wan, H., Zhang, L., & Zhao, H. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s156619 · Cited by 20
Psychopathological and sociodemographic features in treatment-resistant unipolar depression versus bipolar depression: a comparative study
Núñez, N. A., Comai, S., Dumitrescu, E., Ghabrash, M. F., Tabaka, J. M., Saint-Laurent, M., Vida, S., Kolivakis, T., Fielding, A., Low, N. C. P., et al. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1641-y · Cited by 23
Perinatal Administration of a Selective Serotonin Reuptake Inhibitor Induces Impairments in Reproductive Function and Follicular Dynamics in Female Rat Offspring
Moore, C. J., DeLong, N., Chan, K. A., Holloway, A. C., Petrik, J., & Sloboda, D. M. (2015) · Reproductive Sciences · doi:10.1177/1933719115578925 · Cited by 20
Real‐world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in E ast A sia
Hong, J., Novick, D., Montgomery, W. S., Moneta, M. V., Dueñas, H., Peng, X., & Haro, J. M. (2015) · Asia-Pacific Psychiatry · doi:10.1111/appy.12178 · Cited by 19
Tricyclic antidepressants versus ‘active placebo’, placebo or no intervention for adults with major depressive disorder: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis
Kamp, C. B., Juul, S., Siddiqui, F., Barbateskovic, M., Munkholm, K., Hengartner, M. P., Kirsch, I., Gluud, C. N., & Jakobsen, J. C. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01789-0 · Cited by 18
Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy
Nelson, J. C., Rahman, Z. U., Laubmeier, K. K., Eudicone, J. M., McQuade, R. D., Berman, R., Marcus, R. N., Baker, R. A., & Sheehan, J. J. (2014) · CNS Spectrums · doi:10.1017/s109285291300103x · Cited by 19
Use of medication and psychological counselling among Canadians with mood and/or anxiety disorders
O’Donnell, S. C., Syoufi, M., Jones, W. R., & BENNETT, K. J. (2017) · Health Promotion and Chronic Disease Prevention in Canada · doi:10.24095/hpcdp.37.5.04 · Cited by 24
Pharmacological approaches to manage persistent symptoms of major depressive disorder: rationale and therapeutic strategies
Epstein, I., Szpindel, I., & Katzman, M. A. (2014) · Psychiatry Research · doi:10.1016/s0165-1781(14)70003-4 · Cited by 18
Average duration of treatment with antidepressants among concession card holders in Australia
Kjosavik, S. R., Gillam, M., & Roughead, E. E. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415621392 · Cited by 18
Long-term benzodiazepine use in patients taking antidepressants in a public health setting in Brazil: a cross-sectional study
Fulone, I., Silva, M. T., & Lopes, L. C. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-018956 · Cited by 19
Beneficial and harmful effects of antidepressants versus placebo, ‘active placebo’, or no intervention for adults with major depressive disorder: a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses
Juul, S., Siddiqui, F., Barbateskovic, M., Kamp, C. B., Hengartner, M. P., Kirsch, I., Gluud, C. N., & Jakobsen, J. C. (2021) · Systematic Reviews · doi:10.1186/s13643-021-01705-6 · Cited by 18
Long-term naturalistic follow-up of lithium augmentation: Relevance to bipolarity
Inoue, T., Abekawa, T., Nakagawa, S., Suzuki, K., Tanaka, T., Kitaichi, Y., Boku, S., Nakato, Y., Toda, H., & Koyama, T. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.08.022 · Cited by 18
Common Questions About the Pharmacologic Management of Depression in Adults.
Kovich, H., & DeJong, A. (2015) · PubMed · Cited by 18
Antidepressant treatment patterns in younger and older adults from the general population in a real-life setting
Etchepare, F., Sanglier, T., André, M., Verdoux, H., & Tournier, M. (2014) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4081 · Cited by 17
The early improvement of depressive symptoms as a potential predictor of response to antidepressants in depressive patients who failed to respond to previous antidepressant treatments. Analysis of naturalistic data
Bareš, M., Novák, T., Kopeček, M., Stopková, P., Kozeny, J., & Höschl, C. (2012) · European psychiatry · doi:10.1016/j.eurpsy.2011.05.002 · Cited by 17
Overcoming functional impairment in postpartum depressed or anxious women: a pilot trial of desvenlafaxine with flexible dosing
Misri, S. K., Swift, E., Abizadeh, J., & Shankar, R. (2016) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125316656297 · Cited by 17
Evidence-Based, Pharmacological Treatment Guideline for Depression in Korea, Revised Edition
Won, E., Park, S., Han, K.-M., Sung, S.-H., Lee, H.-Y., Paik, J., Jeon, H. J., Lee, M., Shim, S.-H., Ko, Y., et al. (2014) · Journal of Korean Medical Science · doi:10.3346/jkms.2014.29.4.468 · Cited by 17

Authors: Lam, R. W., Kennedy, S. H., Grigoriadis, S., McIntyre, R. S., Milev, R., Ramasubbu, R., Parikh, S. V., Patten, S. B., & Ravindran, A. V.
Affiliations: University of British Columbia (CA)
University of Toronto (CA)
Queen's University (CA)
University of Calgary (CA)
Corresponding author: Lam, Raymond W.
ORCID: Lam, Raymond W.
Kennedy, Sidney H.
Grigoriadis, Sophie
McIntyre, Roger S.
Milev, Roumen
Ramasubbu, Rajamannar
Parikh, Sagar V.
Patten, Scott B.
Ravindran, Arun V.
Venue: Journal of Affective Disorders
Publisher: Elsevier BV
Published: 2009-10
Volume: 117
Pages: S26-S43
ISSN: 0165-0327 (ISSN-L)
DOI: 10.1016/j.jad.2009.06.041
OpenAlex: W38793130
Cited by: 431
References: 150
Citations by year: 2026: 6 · 2025: 4 · 2024: 8 · 2023: 9 · 2022: 13 · 2021: 15 · 2020: 16 · 2019: 18 · 2018: 24 · 2017: 27 · 2016: 41 · 2015: 55 · 2014: 43 · 2013: 49 · 2012: 55
FWCI: 24.76
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Journal of Affective Disorders (publishedVersion)
PubMed (publishedVersion)
Funders: Canadian Network for Mood and Anxiety Treatments
Topics: Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords: major depressive disorder, antidepressant treatment, second-generation antidepressants, first-line therapy, inadequate response, switching strategy, adjunctive therapy, lithium, atypical antipsychotics, tricyclic antidepressants, monoamine oxidase inhibitors, treatment-resistant depression, adults
MeSH terms: Suicide Prevention, Adult, Antidepressive Agents, Depressive Disorder, Major, Major Depressive Disorder, Drug Interactions, Humans, Sexual Dysfunction, Physiological, Selective Serotonin Reuptake Inhibitors, Antidepressive Agents, Second-Generation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks